Company intelligence / Profile preview
Cytokinetics
South San Francisco, California, United Statescytokinetics.com ↗
- Ownership
- Public · CYTK
- Employees
- ~460
- Development stage
- Phase 3
01
Overview
Cytokinetics has advanced its lead program aficamten into late-stage clinical trials for hypertrophic cardiomyopathy. The company’s pipeline includes several first-in-class and next-in-class small molecule drugs targeting cardiac and skeletal muscles. Clinical results have shown promise in improving outcomes for patients with heart failure and HCM. The company continues to expand its research into additional indications related to impaired or declining muscle function.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- small molecules
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →03
Partnerships
Astellas Pharma (licensing/discovery deal for treatments of muscle weakness/fatigue)Ji Xing Pharmaceuticals (commercialization rights for aficamten in China/Asia regions)
04
Financials
- Market cap
- $9.4B
- Total revenue
- $31.9M
- Enterprise value
- $9.5B
Beyond the preview
Go deeper on Cytokinetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytokinetics.